Skip to content

The Effect of Intermittent Theta Burst Magnetic Stimulation Combined with Transcranial Direct Current Stimulation on Cognitive Impairment After Stroke: A Randomized, Double-Blind, Controlled Trial

The Effect of Intermittent Theta Burst Magnetic Stimulation Combined with Transcranial Direct Current Stimulation on Cognitive Impairment After Stroke: A Randomized, Double-Blind, Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120650
Enrollment
Unknown
Registered
2026-03-18
Start date
2025-03-07
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

The iTBS group:Intermittent Theta burst magnetic stimulation
The tDCS group:Transcranial direct current stimulation
Combined group:Intermittent Theta burst magnetic stimulation combined with transcranial direct current stimulation

Sponsors

Chuanbei Medical College Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the diagnostic criteria outlined in the "Diagnostic Key Points for Various Cerebrovascular Diseases" revised by the 4th National Cerebrovascular Disease Academic Conference of the Chinese Medical Association, confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), and diagnosed by certified, experienced doctors as ischemic or hemorrhagic stroke; (2) Aged between 18 and 70 years, within 6 months of the first stroke; (3) Diagnosis of PSCI according to the "PSCI Management Expert Consensus (2017)" using the Mini-Mental State Examination (MMSE) scoring criteria: illiterate <=17 points, elementary education <=20 points; middle school education or above <=24 points; (4) No severe visual or hearing impairments, clear consciousness, and able to complete relevant assessments and tests; (5) Stable vital signs; (6) No skull defects, no intracranial metal, or other contraindications for iTBS/tDCS/fNIRS.

Exclusion criteria

Exclusion criteria: (1) Patients with cognitive impairment caused by neurological diseases other than head trauma or stroke; (2) Patients with aphasia, unstable arrhythmias, or other severe physical diseases; (3) Patients with skull defects, intracranial metal, or other contraindications for iTBS/tDCS/fNIRS; (4) Patients with a history of epilepsy; (5) Patients with visual or hearing impairments; (6) Patients with consciousness disorders; (7) Patients with fever, infection, organ failure, post-stroke depression, or similar conditions.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA) score at the treatment endpoint;

Secondary

MeasureTime frame
Mini-Mental State Examination (MMSE) score at the treatment endpoint;Mandarin version Oxford Cognitive Screen (OCS) score at the treatment endpoint;

Countries

China

Contacts

Public ContactJingyi Lin; Yinxu Wang

Chuanbei Medical College Affiliated Hospital

1047798071@qq.com+86 132 8185 3607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 3, 2026